Herramientas de Accesibilidad

LA UDES PUBLICA
Fecha de publicación:
2014-12-02
Tipo:
Article
Número de artículo:
e114272
Identificación:
SCOPUS_ID:84918792977
eID:
2-s2.0-84918792977
Nombre de la revista:
PLoS ONE
Título del artículo:

Epidemiology, risk factors and genotypes of HBV in HIV-infected patients in the northeast region of Colombia: High prevalence of occult hepatitis B and F3 subgenotype dominance

Introduction: Chronic hepatitis B virus (HBV) infection is an increasing cause of morbidity and mortality in human immunodeficiency virus (HIV)-infected individuals. HIV-positive patients are commonly co-infected with HBV due to shared routes of transmission. Objectives: Our aim was to determine the risk factors, prevalence, genotypes, and mutations of the Surface S gene of HBV, and occult hepatitis B infection (OBI) among patients infected with HIV in a northeastern Colombian city. Methods: A cross-sectional study was conducted with 275 HIV-positive patients attending an outpatient clinic in Bucaramanga, Colombia during 2009-2010. Blood samples were collected and screened for serological markers of HBV (anti-HBs, anti-HBc and HBsAg) through ELISA assay. Regardless of their serological profile, all samples were tested for the HBV S gene by nested-PCR and HBV genotypes were determined by phylogenetic inference. Clinical records were used to examine demographic, clinical, virological, immunological and antiretroviral therapy (ART) variables of HIV infection. Results: Participants were on average 37±11 years old and 65.1% male. The prevalence of HIV-HBV coinfection was 12% (95%CI 8.4-16.4) of which 3.3% had active HBV infection and 8.7% OBI. The prevalence of HIV-HBV coinfection was associated with AIDS stage and ART treatment. Sequence analysis identified genotype F, subgenotype F3 in 93.8% of patients and genotype A in 6.2% of patients. A C149R mutation, which may have resulted from failure in HBsAg detection, was found in one patient with OBI. Conclusions: The present study found a high prevalence of HIV-HBV coinfection with an incidence of OBI 2.6-fold higher compared to active HBV infection. These findings suggest including HBV DNA testing to detect OBI in addition to screening for HBV serological markers in HIV patients.

Autor(es) UDES:
Bautista-Amorocho H., Castellanos-Domínguez Y.Z., Velandia-Cruz S.A., Becerra-Peña J.A., Farfán-García A.E.
Otros Autores:
Rodríguez-Villamizar L.A.
Autor Principal:
Bautista-Amorocho H.
Áreas del conocimiento:
Biochemistry, Genetics and Molecular Biology (all), Agricultural and Biological Sciences (all), Multidisciplinary
Acerca de la revista donde se publicó este artículo:

PLoS ONE

Cuartil Q1
Ranking
5108
Tipo
Journal
eISSN
19326203
Región
Northern America
País
United States
Volumen
9
Cobertura
2006-2022
Logo o escudo de Universidad de Santander UDES - Con acreditación de Alta Calidad (Bucaramanga)
Servicios
Sistema Génesis Sistema GALILEO Directorio Telefónico Chat en línea